Sanders Capital LLC grew its holdings in shares of UnitedHealth Group Inc (NYSE:UNH) by 50.2% in the second quarter, HoldingsChannel reports. The fund owned 4,626,666 shares of the healthcare conglomerate’s stock after buying an additional 1,546,140 shares during the period. UnitedHealth Group makes up about 5.2% of Sanders Capital LLC’s portfolio, making the stock its 5th largest holding. Sanders Capital LLC’s holdings in UnitedHealth Group were worth $1,255,689,000 as of its most recent SEC filing.
A number of other hedge funds have also made changes to their positions in UNH. Norges Bank acquired a new position in UnitedHealth Group during the 4th quarter worth $2,343,175,000. Thoroughbred Financial Services LLC boosted its position in UnitedHealth Group by 25,321.4% during the 2nd quarter. Thoroughbred Financial Services LLC now owns 1,922,872 shares of the healthcare conglomerate’s stock worth $192,287,000 after acquiring an additional 1,915,308 shares during the period. FMR LLC boosted its position in UnitedHealth Group by 1.9% during the 4th quarter. FMR LLC now owns 64,480,003 shares of the healthcare conglomerate’s stock worth $16,063,258,000 after acquiring an additional 1,232,189 shares during the period. Geode Capital Management LLC boosted its position in UnitedHealth Group by 9.1% during the 4th quarter. Geode Capital Management LLC now owns 11,593,401 shares of the healthcare conglomerate’s stock worth $2,882,988,000 after acquiring an additional 965,763 shares during the period. Finally, American Century Companies Inc. boosted its position in UnitedHealth Group by 12.8% during the 4th quarter. American Century Companies Inc. now owns 5,678,706 shares of the healthcare conglomerate’s stock worth $1,414,679,000 after acquiring an additional 644,872 shares during the period. Institutional investors own 85.87% of the company’s stock.
Shares of UnitedHealth Group stock traded down $1.73 on Friday, reaching $247.52. 130,002 shares of the company were exchanged, compared to its average volume of 3,551,316. The business has a fifty day simple moving average of $251.46. The stock has a market cap of $242.27 billion, a price-to-earnings ratio of 19.23, a price-to-earnings-growth ratio of 1.36 and a beta of 0.61. The company has a debt-to-equity ratio of 0.62, a current ratio of 0.67 and a quick ratio of 0.73. UnitedHealth Group Inc has a fifty-two week low of $208.07 and a fifty-two week high of $287.94.
In other UnitedHealth Group news, Director William C. Ballard, Jr. sold 12,000 shares of the business’s stock in a transaction dated Tuesday, July 23rd. The stock was sold at an average price of $255.31, for a total value of $3,063,720.00. Following the transaction, the director now owns 61,309 shares in the company, valued at $15,652,800.79. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, Director Richard T. Burke sold 10,000 shares of the business’s stock in a transaction dated Wednesday, May 29th. The shares were sold at an average price of $241.99, for a total value of $2,419,900.00. Following the completion of the transaction, the director now owns 187,663 shares in the company, valued at approximately $45,412,569.37. The disclosure for this sale can be found here. Insiders have sold 37,000 shares of company stock worth $9,158,720 over the last three months. 0.87% of the stock is owned by insiders.
A number of research firms have recently commented on UNH. Cantor Fitzgerald set a $310.00 price objective on UnitedHealth Group and gave the stock a “buy” rating in a research note on Friday, July 19th. Royal Bank of Canada set a $311.00 price objective on UnitedHealth Group and gave the stock a “buy” rating in a research note on Friday, July 19th. SunTrust Banks dropped their price objective on UnitedHealth Group to $300.00 and set a “buy” rating on the stock in a research note on Wednesday, April 17th. They noted that the move was a valuation call. Bank of America reissued a “buy” rating and issued a $290.00 price objective (down previously from $320.00) on shares of UnitedHealth Group in a research note on Wednesday, April 17th. Finally, Cleveland Research reissued a “buy” rating on shares of UnitedHealth Group in a research note on Monday, July 15th. One analyst has rated the stock with a sell rating, one has assigned a hold rating and eighteen have issued a buy rating to the company’s stock. The stock has an average rating of “Buy” and an average target price of $295.06.
UnitedHealth Group Profile
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight, and OptumRx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health and well-being services to individuals age 50 and older, addressing their needs for preventive and acute health care services, as well as services dealing with chronic disease and other specialized issues for older individuals; and Medicaid plans, Children's Health Insurance Program, and health care programs; and health and dental benefits.
Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Inc (NYSE:UNH).
Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.